Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Transcenta Holding Limited ( (HK:6628) ) is now available.
Transcenta Holding Limited has successfully completed the placement of 14,400,000 new shares under a general mandate, raising approximately HK$59.34 million. This strategic move, facilitated by BOCI Asia Limited, aims to strengthen the company’s financial position and potentially enhance its market presence, with the new shares being issued to independent third-party investors.
The most recent analyst rating on (HK:6628) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Transcenta Holding Limited stock, see the HK:6628 Stock Forecast page.
More about Transcenta Holding Limited
Transcenta Holding Limited is a biotechnology company registered in the Cayman Islands. It focuses on the development and commercialization of innovative therapies, primarily in the field of oncology and other critical diseases.
Average Trading Volume: 4,082,411
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.94B
Find detailed analytics on 6628 stock on TipRanks’ Stock Analysis page.